Tag Archives: layoffs

Pfizer NYC Tower Up For Sale

By George Koroneos | Published: May 11, 2010
Image by Getty Images via Daylife Pfizer’s New York tower is on the market, but the pharma giant is not planning on leaving Manhattan. The New York Times, on Tuesday, reported that the company is willing to put millions of dollars in tax breaks on the line to consolidate its New York offices. “We are looking [at selling] [...]
Posted in Strategy | Also tagged , , , | Leave a comment

AstraZeneca to Slash 8,000 More Jobs (Updated 2/3/10)

By Oriana Schwindt | Published: January 28, 2010
Last year, AstraZeneca announced the elimination of some 15,000 jobs. Last Thursday, the London-based company revealed that it plans to lay off another 8,000 by 2014—this despite global revenue growth of 4 percent for 2009. Much of the drive for this addition labor sculpting stems from AZ’s desire to streamline its R&D; the company will focus [...]
Posted in Strategy | Also tagged , , , , , , , | 1 Comment

Cold Cuts: Merck Layoffs Loom

By Reid Paul | Published: January 7, 2010
Image via Wikipedia It is not just cold outside these days, as Merck & Co. makes some cold hard decisions. Following on the heels of its now closed acquisition of Schering-Plough, Merck is making significant job cuts across its operations. Some 16,000 jobs are expected to be eliminated in total as a result of the merger. According [...]
Posted in Strategy | Also tagged , , , | Leave a comment

AstraZeneca, BMS Announce Layoffs and Buyouts

By George Koroneos | Published: October 21, 2009
AstraZeneca was the topic of conversation this week as word broke that the company is offering buyout deals to every member of its 5,500 US sales force. “AstraZeneca is making changes to our sales force, which will be managed first by looking at vacancies and offering field sales employees the opportunity to self-identify whether they are [...]
Posted in Strategy | Also tagged , , , , , , , | 1 Comment

Pharma Layoffs Continue

By Cassandra Blohowiak | Published: March 4, 2009
It’s been another tough few weeks for pharma employees as four more companies handed out pink slips in an effort to trim bottom lines. Elan cut 14 percent of its global work force last Wednesday as a part of an ongoing strategic review process. The company announced that it would postpone biologics manufacturing, redesign R&D in [...]
Posted in Strategy | Also tagged , , , , , | 1 Comment